Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192369 | SCV000248945 | benign | not specified | 2019-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001529698 | SCV001797278 | likely benign | not provided | 2022-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001529698 | SCV002468640 | likely benign | not provided | 2024-04-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002517980 | SCV003714519 | likely benign | Inborn genetic diseases | 2021-09-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001529698 | SCV003917642 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | SMARCA2: BS1, BS2 |
Molecular Genetics, |
RCV003993879 | SCV004812831 | benign | Nicolaides-Baraitser syndrome | 2023-06-06 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529698 | SCV001743603 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001529698 | SCV001797399 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529698 | SCV001975398 | likely benign | not provided | no assertion criteria provided | clinical testing |